November 3, 2010
Two Billion Dollar Cancer Deal Sealed by US Drug Distributor
Cancer specialist US Oncology will be bought by McKesson, a leading US drug distributor, in a stock-and-debt deal worth about 2.16 billion dollars, the companies said.
Cancer specialist US Oncology will be bought by McKesson, a leading US drug distributor, in a stock-and-debt deal worth about 2.16 billion dollars, the companies said.
Leave a Comment